Article Text

AB0030 The LP13.3 genomic region -RS599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis
  1. R. Lόpez-Mejías1,
  2. C. González-Juanatey2,
  3. M. García-Bermúdez3,
  4. S. Castañeda4,
  5. J.A. Miranda-Filloy5,
  6. R. Blanco1,
  7. J. Llorca6,
  8. J. Martín7,
  9. M.A. González-Gay8
  1. 1Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Ifimav, Santander
  2. 2Cardiology Division, Hospital Xeral-Calde, Lugo
  3. 3Instituto de Parasitología y Biomedicina Lόpez-Neyra, Ipbln-Csic, Granada
  4. 4Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid
  5. 5Division of Rheumatology, Hospital Xeral-Calde, Lugo
  6. 6Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Ifimav, Santander
  7. 7Instituto de Parasitología y Biomedicina Lόpez-Neyra, Ipbln-Csic, Granada
  8. 8Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Ifimav, Santander, Spain


Background Rheumatoid arthritis (RA) is a complex polygenic autoimmune inflammatory disease with high risk of cardiovascular (CV) complications as consequence of accelerated atherosclerosis [1]. Recent studies have emphasized the relevance of several genetic polymorphisms in the susceptibility to CV disease in RA [2, 3]. Genome-wide association studies (GWAS) revealed that the polymorphism rs599839 (A>G) is associated with CAD [4]and with higher plasma total and LDL cholesterol levels [5].

Objectives Wwe aimed to determine, for first time, the potential role of rs599839 polymorphism in the development of endothelial dysfunction in a cohort of RA patients without clinically evident CV disease.

Methods 128 RA patients without history of CV events were genotyped for rs599839 A/G polymorphism. Presence of endothelial dysfunction was assessed by brachial ultrasonography (brachial flow-mediated endothelium-dependent [FMD]).

Results Patients carrying the allele G exhibited more severe endothelial dysfunction (FMD%: 4.61±3.94%) than those carrying the wild allele A (FMD%: 6.01±5.15%) (p=0.08). Adjustment for gender, age at the time of study, follow-up time and classic CV risk factors disclosed a significant association between the rs599839 polymorphism and FMD (G vs. A: p=0.0062).

Conclusions Our results confirm an association of the rs599839 polymorphism with endothelial dysfunction in RA.

This study was supported by two grants from “Fondo de Investigaciones Sanitarias” PI06-0024 and PI09/007/48 (Spain) and partially supported by RETICS Program, RD08/0075 (RIER) from ``Instituto de Salud Carlos III'' (ISCIII).

  1. Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52:3045-3053.

  2. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57:125-132.

  3. Rodriguez-Rodriguez L, Gonzalez-Juanatey C, Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011;216:125-30.

  4. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-453.

  5. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40:189-197.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.